Regencell Bioscience Holdings Ltd. (RGC): Price and Financial Metrics
RGC Price/Volume Stats
| Current price | $6.37 | 52-week high | $32.44 |
| Prev. close | $6.60 | 52-week low | $3.03 |
| Day low | $5.78 | Volume | 106,591 |
| Day high | $6.71 | Avg. volume | 101,954 |
| 50-day MA | $5.92 | Dividend yield | N/A |
| 200-day MA | $6.53 | Market Cap | 82.89M |
RGC Stock Price Chart Interactive Chart >
Regencell Bioscience Holdings Ltd. (RGC) Company Bio
Regencell Bioscience Holdings Ltd. engages in the research, development, and commercialization of traditional Chinese medicine. It seeks for the treatment of neurocognitive disorders and degeneration, specifically attention deficit and hyperactivity disorder and autism spectrum disorder. The company was founded by Yat-Gai Au on October 30, 2014 and is headquartered in Hong Kong.
RGC Price Returns
| 1-mo | 25.15% |
| 3-mo | -19.87% |
| 6-mo | 27.40% |
| 1-year | -46.92% |
| 3-year | -76.62% |
| 5-year | N/A |
| YTD | -39.33% |
| 2023 | N/A |
| 2022 | 0.00% |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...